Review
Open access
Jul 2026
Immune checkpoint inhibitors in advanced cholangiocarcinoma: a systematic review of efficacy, safety, and emerging biomarkers
Triplet and locoregional combinations show encouraging efficacy, warranting further validation, and biomarker-driven selection, particularly HRD/DDR status and ctDNA monitoring, will be critical to optimizing outcomes.
Faiz Un Nisa, M. Ali, Talha Khan et al.
· Journal of the Egyptian Nati... · 0 citations